Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
218
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
+402K
-
Total reported value, excl. options
-
$1.39B
-
Value change
-
+$12.2M
-
Put/Call ratio
-
0.22
-
Number of buys
-
103
-
Number of sells
-
-105
-
Price
-
$26.18
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q1 2021
261 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2021.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
of 56M outstanding shares and own 94.91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.99M shares), VANGUARD GROUP INC (5.45M shares), ARMISTICE CAPITAL, LLC (3.41M shares), DIMENSIONAL FUND ADVISORS LP (2.13M shares), MACQUARIE GROUP LTD (2.08M shares), STATE STREET CORP (1.78M shares), RENAISSANCE TECHNOLOGIES LLC (1.76M shares), GW&K Investment Management, LLC (1.57M shares), ASHFORD CAPITAL MANAGEMENT INC (1.23M shares), and Stephens Investment Management Group LLC (1.14M shares).
This table shows the top 218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.